相关实验视频
Updated: Jan 9, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
875
卫生专业人员的超重/肥胖以及相关因素
Sirlaine de Pinho1, Lucineia de Pinho1, Carla Silvana de Oliveira E Silva1
1Universidade Estadual de Montes Claros. Montes Claros, Minas Gerais, Brazil.
Revista brasileira de enfermagem
|December 10, 2025
概括
在巴西的卫生专业人员中,超重和肥胖非常普遍. 诸如年龄较大,医疗保健工作经验较长,健康标志物较高等因素与更高的发病率有关.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 职业健康 职业健康 职业健康
背景情况:
- 超重和肥胖的高率对健康构成重大风险.
- 卫生专业人员对公共卫生至关重要,但面临着职业压力因素.
- 了解这一群体中超重/肥胖的患病率和因素至关重要.
研究的目的:
- 确定卫生专业人员中超重/肥胖的流行率.
- 确定与该人口中超重/肥胖相关的社会人口统计学,职业和健康相关因素.
主要方法:
- 在巴西米纳斯吉拉斯州北部的九家医院进行了横截面研究.
- 包括在关键病房至少有六个月经验的卫生专业人员.
- 收集关于社会人口统计,职业,人体统计和健康状况的数据;使用波桑回归分析.
主要成果:
- 共有490名卫生专业人员参与.
- 超重/肥胖的流行率为61.8%.
- 相关因素包括30岁或以上的年龄,超过5年的医疗保健,高甘油和高血压.
结论:
- 超重/肥胖在研究的医疗保健专业人员中非常普遍.
- 关键的相关因素包括年龄,多年的经验和特定的健康指标.
- 促进生活方式变化的干预措施对于这一群体是必要的.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients
198
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
198
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
221
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
221
Stress Prevention and Stress Management Techniques IV
214
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
214
Lifestyle Factors and Health
395
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
395
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
159
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159

